Chips · Stock report · Camtek (NASDAQ: CAMT)
Camtek — our money-flow reading fell to -20.7 as the stock hit a new 52-week low at $91.92
The Closelooknet read
Camtek (NASDAQ: CAMT) is losing ground on our own gauges. Our money-flow reading (a gauge of net buying pressure) stands at -20.7, down 10.2 points in five sessions, and it is falling faster. Over the past month the stock ranks 62nd of the 86 stocks in our chip section, with a move of -39.61%. Its momentum score is 9 and its composite 41, and the close of $91.92 on 5 November is a new 52-week low. What we watch: whether the flow reading stops falling and the stock closes back above $94.40, the prior 52-week low close, or keeps slipping under it.
Where Camtek stands among our chip stocks
Camtek's one-month move of -39.61% sits inside the range of its testing and metrology peers in our section. Onto Innovation (ONTO) is at -48.75%, FormFactor (FORM) at -48.67%, Teradyne (TER) at -48.34% and Cohu (COHU) at -50.69%. KLA Corp (KLAC) is at -34.05% and Technoprobe (TPRO.MI) at -38.52%. Smaller falls show up at Advantest (6857.T) -26.84%, Lasertec (6920.T) -27.32% and Nova (NVMI) -25.8%.
On the year, Camtek is down 13.56%, while Advantest is up 50.17% and Technoprobe up 86.99%. Camtek is 55.69% below its 52-week high; Nova is 53.72% below its high.
Our money-flow and quality readings
Our money-flow reading is -20.7, down 10.2 points over five sessions and falling faster. Camtek's composite score is 41 of 100. Quality is 62, balance sheet 75 and cash quality 72, while growth is 42, valuation 21, capital allocation 22 and momentum 9.
The Piotroski score, a check of financial health, is scored 5 of 9.
Price trend
Camtek closed at $91.92, down 9.4% on the day and 27.43% over five sessions. It opened with a gap of -4.72%. The close sits 33.25% below its 50-day average of $137.70 and 41.33% below the average close of the last 200 sessions, $156.68. The 52-week high close was $207.46 on 11 May 2026. Its typical daily swing is about 4.1%, and the latest drop was 2.28 times that.
Closelooknet is a research diary. Nothing here is investment advice or a recommendation to buy or sell.